"Effectiveness of a Brief Intervention for Substances Consumption Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): A Randomized Control Trial in Chilean Primary Care."

NCT ID: NCT01573416

Last Updated: 2013-10-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-31

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Alcohol and drugs consumption are among the highest risk factor for health in Chile and abroad. In Chile, harmful use of alcohol continues to be a major contributor to the burden of disease while lost years of healthy life are higher than many other risk factors such as hypertension, overweight and obesity, and hyperglycemia. It is important to say that the impact of alcohol consumption is greater in younger age groups where fatal injuries occur relatively early in life, as well.

In Chile, the consumption pattern in 2008 showed that 49.8 % consumed at least once in the last month for alcohol, 3.5 % for marihuana and 1.3 % for cocaine. This prevalence was even greater in young adults and adolescents and is associated with other mental health issues and poorer life quality. Those who have consumed marihuana during the last year, 25% report dependence symptoms. For cocaine derives, dependency rises up to 50% among the consumers. This data reinforce the need to design and implement strategies for reducing alcohol and drugs consumption in our population.

Also, it is well known that a high number of those who suffers from any addiction problem do not get attention in a specialized center. The are many barriers to do so, such as lack of motivation, lack of resources, social problems, access to care problems, and so on.

Chile has a shortage of preventive interventions for those at risk to develop an addiction at an early stage of substance use because front line health services (Primary health care and emergency care) and other social services (police stations, local justice courts) do not have a screening system and a model of brief intervention.

The Pontificia Universidad Catolica de Chile, through its Addiction Studies Center (CEDA UC) and its Department of Family Medicine, is working in conjunction with SENDA (Servicio Nacional para la Prevención y Rehabilitación del Consumo de Drogas y Alcohol ) to design, implement and evaluate a communal system for early detection, brief intervention and referral to treatment (SBIRT), in people older than 18 years, with substance consumption in five municipalities in the country.

The aid of this study is to demonstrate that a model of brief intervention is more effective than the approach currently used in patients with substance use at moderate risk (i.e.follow-up). It is a multicentric randomized controlled trial, single blind, with a group to receive brief intervention and a control group that is kept in control and waiting list being re-evaluated three months later.

The target population is composed by users whose ASSIST screening scores place them in the moderate risk group, for which there has not been defined a structured intervention yet by our health system. The information will be obtained from the scores obtained after the application of the ASSIST-WHO questionnaire.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcohol-Related Disorders Substance-Related Disorders Substance Abuse

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Alcohol Abuse Drugs Brief intervention ASSIST

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

Group Type PLACEBO_COMPARATOR

Observation

Intervention Type OTHER

Subjects who obtain a moderate risk score in the ASSIST screening questionnaire and after randomization are selected for the control group, will receive a brochure with substance-abuse information without any further conversation about the subject with the caregiver. This observation group will be re-evaluated after 3 months with the same ASSIST screening instrument.

Intervention group

Group Type ACTIVE_COMPARATOR

ASSIST-linked brief intervention for hazardous and harmful substance use.

Intervention Type OTHER

ASSIST-linked brief intervention will be applied to users achieving moderate risk scores in the ASSIST questionnaire. If after randomization are selected to enter the intervention group, they will receive a ten minute counseling carried immediately after the screening instrument. This intervention group will be re-evaluated after 3 months with the same ASSIST screening instrument.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ASSIST-linked brief intervention for hazardous and harmful substance use.

ASSIST-linked brief intervention will be applied to users achieving moderate risk scores in the ASSIST questionnaire. If after randomization are selected to enter the intervention group, they will receive a ten minute counseling carried immediately after the screening instrument. This intervention group will be re-evaluated after 3 months with the same ASSIST screening instrument.

Intervention Type OTHER

Observation

Subjects who obtain a moderate risk score in the ASSIST screening questionnaire and after randomization are selected for the control group, will receive a brochure with substance-abuse information without any further conversation about the subject with the caregiver. This observation group will be re-evaluated after 3 months with the same ASSIST screening instrument.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women older than 18 years and 50 years
* Achieving a moderate risk score in the ASSIST screening questionnaire.
* Without any similar intervention in the last 3 months. (ie. AUDIT test).

Exclusion Criteria

* Pregnant women.
* Users with cognitive disabilities.
* Users with language and communication disabilities.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Servicio Nacional para la Prevención y Rehabilitación del Consumo de Drogas y Alcohol (SENDA)

UNKNOWN

Sponsor Role collaborator

Pontificia Universidad Catolica de Chile

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fernando Poblete Arrué

Profesor Asistente Adjunto

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Fernando Poblete, MD, MPH

Role: STUDY_DIRECTOR

Pontificia Universidad Catolica de Chile

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CESFAM Dr. Sergio Aguilar

Coquimbo, IV, Chile

Site Status

CESFAM San Juan

Coquimbo, IV, Chile

Site Status

CESFAM Santa Cecilia

Coquimbo, IV, Chile

Site Status

CESFAM Tierras Blancas

Coquimbo, IV, Chile

Site Status

SAPU Dr. Sergio Aguilar

Coquimbo, IV, Chile

Site Status

SAPU Tierras Blancas

Coquimbo, IV, Chile

Site Status

5ta. Comisaría Conchalí

Conchalí, RM, Chile

Site Status

CS Alberto Bachelet

Conchalí, RM, Chile

Site Status

CS José Symon Ojeda

Conchalí, RM, Chile

Site Status

CS Juanita Aguirre

Conchalí, RM, Chile

Site Status

CS Lucas Sierra

Conchalí, RM, Chile

Site Status

SAPU Lucas Sierra

Conchalí, RM, Chile

Site Status

43va. Comisaría Peñalolén

Peñalolén, RM, Chile

Site Status

CESFAM Lo Hermida

Peñalolén, RM, Chile

Site Status

CESFAM Padre Gerardo Whelan

Peñalolén, RM, Chile

Site Status

CS Carol Urzúa Ibañez

Peñalolén, RM, Chile

Site Status

CS La Faena

Peñalolén, RM, Chile

Site Status

SAPU Lo Hermida

Peñalolén, RM, Chile

Site Status

26va. Comisaría Pudahuel

Pudahuel, RM, Chile

Site Status

CESFAM Gustavo Molina

Pudahuel, RM, Chile

Site Status

CESFAM RAúl Silva Henríquez

Pudahuel, RM, Chile

Site Status

CESFAM Violeta Parra

Pudahuel, RM, Chile

Site Status

Consultorio Estrella

Pudahuel, RM, Chile

Site Status

SAPU La Estrella

Pudahuel, RM, Chile

Site Status

14va. Comisaría San Bernardo

San Bernardo, RM, Chile

Site Status

APS Carol Urzúa

San Bernardo, RM, Chile

Site Status

APS Confraternidad

San Bernardo, RM, Chile

Site Status

APS El Manzano

San Bernardo, RM, Chile

Site Status

APS Raúl Cuevas

San Bernardo, RM, Chile

Site Status

SAPU Raúl Brañes

San Bernardo, RM, Chile

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Chile

References

Explore related publications, articles, or registry entries linked to this study.

Humeniuk R, Ali R, Babor T, Souza-Formigoni ML, de Lacerda RB, Ling W, McRee B, Newcombe D, Pal H, Poznyak V, Simon S, Vendetti J. A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction. 2012 May;107(5):957-66. doi: 10.1111/j.1360-0443.2011.03740.x. Epub 2012 Feb 28.

Reference Type BACKGROUND
PMID: 22126102 (View on PubMed)

Beich A, Thorsen T, Rollnick S. Screening in brief intervention trials targeting excessive drinkers in general practice: systematic review and meta-analysis. BMJ. 2003 Sep 6;327(7414):536-42. doi: 10.1136/bmj.327.7414.536.

Reference Type BACKGROUND
PMID: 12958114 (View on PubMed)

Ballesteros J, Duffy JC, Querejeta I, Arino J, Gonzalez-Pinto A. Efficacy of brief interventions for hazardous drinkers in primary care: systematic review and meta-analyses. Alcohol Clin Exp Res. 2004 Apr;28(4):608-18. doi: 10.1097/01.alc.0000122106.84718.67.

Reference Type BACKGROUND
PMID: 15100612 (View on PubMed)

Hungerford DW, Pollock DA, Todd KH. Acceptability of emergency department-based screening and brief intervention for alcohol problems. Acad Emerg Med. 2000 Dec;7(12):1383-92. doi: 10.1111/j.1553-2712.2000.tb00496.x.

Reference Type BACKGROUND
PMID: 11099429 (View on PubMed)

Anderson PA, Grey SF, Nichols C, Parran TV Jr, Graham AV. Is screening and brief advice for problem drinkers by clergy feasible? A survey of clergy. J Drug Educ. 2004;34(1):33-40. doi: 10.2190/3QH2-VLWN-ELWM-KC67.

Reference Type BACKGROUND
PMID: 15468746 (View on PubMed)

Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus. 2007;28(3):7-30. doi: 10.1300/J465v28n03_03.

Reference Type BACKGROUND
PMID: 18077300 (View on PubMed)

Gentilello LM, Rivara FP, Donovan DM, Jurkovich GJ, Daranciang E, Dunn CW, Villaveces A, Copass M, Ries RR. Alcohol interventions in a trauma center as a means of reducing the risk of injury recurrence. Ann Surg. 1999 Oct;230(4):473-80; discussion 480-3. doi: 10.1097/00000658-199910000-00003.

Reference Type BACKGROUND
PMID: 10522717 (View on PubMed)

Babor TF, Kadden RM. Screening and interventions for alcohol and drug problems in medical settings: what works? J Trauma. 2005 Sep;59(3 Suppl):S80-7; discussion S94-100. doi: 10.1097/01.ta.0000174664.88603.21.

Reference Type BACKGROUND
PMID: 16355071 (View on PubMed)

WHO ASSIST Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002 Sep;97(9):1183-94. doi: 10.1046/j.1360-0443.2002.00185.x.

Reference Type BACKGROUND
PMID: 12199834 (View on PubMed)

Whitlock EP, Polen MR, Green CA, Orleans T, Klein J; U.S. Preventive Services Task Force. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004 Apr 6;140(7):557-68. doi: 10.7326/0003-4819-140-7-200404060-00017.

Reference Type BACKGROUND
PMID: 15068985 (View on PubMed)

Hawks D. Broadening the base of treatment for alcohol problems: a report which deserves to be debated. The limits of treatment and importance of prevention. Br J Addict. 1991 Jul;86(7):848-9. doi: 10.1111/j.1360-0443.1991.tb01836.x. No abstract available.

Reference Type BACKGROUND
PMID: 1912733 (View on PubMed)

Greene MC, Kane J, Alto M, Giusto A, Lovero K, Stockton M, McClendon J, Nicholson T, Wainberg ML, Johnson RM, Tol WA. Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries. Cochrane Database Syst Rev. 2023 May 9;5(5):CD013350. doi: 10.1002/14651858.CD013350.pub2.

Reference Type DERIVED
PMID: 37158538 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://medicina.uc.cl

Pontificia Universidad Católica de Chile, School of Medicine

http://www.senda.gob.cl

Servicio Nacional para la Prevención y Rehabilitación del Consumo de Drogas y Alcohol (SENDA)

http://medicinafamiliar.uc.cl

Family Medicine Dept., Pontificia Universidad Católica de Chile, School of Medicine.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEDAUC-11-205

Identifier Type: -

Identifier Source: org_study_id